Adeshwar Meditex Limited
BSE: ADESHWAR · Healthcare Research, Analytics & Technology · sector
Key numbers
Last 12 months to Mar 2026, Standalone. "Sector median" = middle value of 9 companies in Healthcare Research, Analytics & Technology (P/E median leaves out loss-making companies). Tap ? for what a number means.
Things to know
- Operating profit covered interest 4.0x in the last 12 months.
- Other income was 8% of net profit in the last 12 months.
- No dividend in the last 5 financial years.
- Price ₹15.80 on 2026-10-26: -25.5% from the 52-week high, +21.5% from the 52-week low.
Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.
Charts
Quarterly results
| ₹ cr | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|
| Revenue | 37 | 30 | 26 |
| EBITDA | 2 | 2 | 1 |
| OPM % | 5.8% | 5.1% | 4.7% |
| Other income | 0 | 0 | 0 |
| Net profit | 1 | 1 | 1 |
| EPS (₹) | 0.93 | 0.51 | 0.37 |
Standalone figures where filed. Latest quarter Mar 2026.
Profit & loss (yearly)
| ₹ cr | FY22 | FY23 | FY24 | FY25 | FY26 | TTM |
|---|---|---|---|---|---|---|
| Revenue | 65 | 82 | 80 | 84 | 56 | 56 |
| EBITDA | 3 | 5 | 5 | 4 | 3 | 3 |
| Net profit | 1 | 2 | 2 | 2 | 1 | 1 |
| EPS (₹) | 0.55 | 1.44 | 1.39 | 1.43 | 0.88 | 0.88 |
| Revenue growth | +27.2% | -3.0% | +4.8% | -33.0% | – | |
| Profit growth | +162.0% | -2.9% | +3.0% | -39.1% | – | |
| Dividend / share (₹) | – | – | – | – | – |
| Compounded growth | 3 years | 5 years | Last 12 months |
|---|---|---|---|
| Sales | -12.0% | – | – |
| Net profit | -15.1% | – | – |
| EPS | -15.1% | – | – |
| Share price | – | -7.7% (2y) | -2.0% |
Balance sheet
| ₹ cr | FY25 | FY26 |
|---|---|---|
| Shareholders' equity | 23 | 24 |
| Cash & equivalents | 3 | 0 |
| Total assets | 72 | 50 |
| Fixed assets | 3 | 3 |
| Investments | 0 | 0 |
| Inventory | 26 | 20 |
Year-end figures from the March annual filing.
Cash flow
| ₹ cr | FY25 | FY26 |
|---|---|---|
| Cash from operations | 4 | 5 |
| Cash from investing | 1 | 0 |
| Cash from financing | -3 | -7 |
| Capex | 0 | 0 |
| Free cash flow | 4 | 5 |
Free cash flow = cash from operations − capex.
Ratios by year
| ₹ cr | FY25 | FY26 |
|---|---|---|
| ROE % | 9.2% | 5.3% |
| ROCE % | 18.3% | 10.2% |
| Inventory days | 127 | 159 |
| Working capital days | 148 | 225 |
Peers in Healthcare Research, Analytics & Technology
| Company | Market cap | P/E | P/B | ROE | ROCE | OPM | Sales 3y | Div yield |
|---|---|---|---|---|---|---|---|---|
| SYNGENE | ₹14,527 cr | 65.4x | 3.0x | 4.6% | 7.0% | 19.8% | +5.4% | 0.35% |
| INDGN | ₹14,472 cr | 36.0x | 4.6x | 13.9% | 17.4% | 16.2% | – | 0.33% |
| SUVEN | ₹6,917 cr | – | 11.7x | -100.5% | -59.5% | -4,155.5% | -19.3% | – |
| VIMTALABS | ₹2,185 cr | 27.4x | 4.8x | 19.1% | 23.5% | 34.3% | +8.9% | 0.20% |
| BI | ₹189 cr | 4.3x | 1.0x | 2.3% | 7.0% | 8.4% | +274.4% | – |
| TAKE | ₹154 cr | 12.1x | 5.0x | 49.8% | 20.1% | -2.0% | -34.1% | – |
| NOVELIX | ₹141 cr | 31.7x | 3.0x | 11.3% | 8.8% | 3.1% | +411.3% | – |
| JSTL | ₹102 cr | 28.5x | 1.4x | 6.1% | 9.8% | 20.5% | +19.4% | 0.97% |
| ADESHWAR | ₹23 cr | 18.0x | 0.9x | 5.5% | 10.2% | 4.9% | -12.0% | – |
All 9 companies in Healthcare Research, Analytics & Technology →
Documents
Links go to the original files on the exchange website.
About the company
| Sector | Healthcare |
| Industry | Healthcare Research, Analytics & Technology |
| Sub-industry | Healthcare Research, Analytics & Technology |
| Symbol | ADESHWAR |
| BSE code | 543309 |
| ISIN | INE0H8J01015 |
| Face value | ₹10.0 |
| Incorporated | – |
| Website | – |
| Plants (India / abroad) | – |
Data built 2026-10-24 from BSE company filings (inline XBRL: Integrated Filing - Finance) + BSE results summary for earlier years; price = BSE close 2026-10-26.